510(k) K254032

QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B by QIAGEN GmbH — Product Code PCH

K254032 is an FDA 510(k) premarket notification submitted by QIAGEN GmbH for the device "QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B". The FDA issued a decision of Substantially Equivalent on Mar 9, 2026. The device falls under product code PCH (Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System), a Class II device regulated under 21 CFR 866.3990. QIAGEN GmbH has 17 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 9, 2026
Date Received
Dec 16, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
Device Class
Class II
Regulation Number
866.3990
Review Panel
MI
Submission Type
510(k)

A gastrointestinal pathogen panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal microbial nucleic acids extracted from human stool specimens. The detection and identification of a specific gastrointestinal microbial nucleic acid from individuals exhibiting signs and/or symptoms of gastrointestinal infection aids in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation and other laboratory findings.

Need the full FDA record for QIAGEN GmbH? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K254032. Report a data issue: hello@regdatalab.com.